What is a common long-acting insulin drug?

What is a common long-acting insulin drug?

• A. NPH (Humulin N)
• B. Lispro (Humalog)
• C. Lantus
• D. Humalin R

Answer: (C)

Lantus is a well-known long-acting insulin that is designed to provide a steady release of insulin over a 24-hour period. This characteristic makes it particularly useful for managing blood glucose levels in individuals with diabetes, allowing for sustained control throughout the day and night. Lantus mimics the body's natural insulin release and is typically administered once daily, making it convenient for patients who need to maintain consistent insulin levels. On the other hand, other options represent different types of insulin. NPH, or Humulin N, is an intermediate-acting insulin, which means it starts working more quickly than Lantus but does not provide the same prolonged action. Lispro (Humalog) is a rapid-acting insulin that works quickly to help control blood sugar during meals, while Humulin R is a short-acting insulin that also works relatively quickly but for a shorter duration. These differences in pharmacokinetics define how each type of insulin is utilized in diabetes management.

Lantus is a well-known long-acting insulin that is designed to provide a steady release of insulin over a 24-hour period. This characteristic makes it particularly useful for managing blood glucose levels in individuals with diabetes, allowing for sustained control throughout the day and night. Lantus mimics the body's natural insulin release and is typically administered once daily, making it convenient for patients who need to maintain consistent insulin levels.

On the other hand, other options represent different types of insulin. NPH, or Humulin N, is an intermediate-acting insulin, which means it starts working more quickly than Lantus but does not provide the same prolonged action. Lispro (Humalog) is a rapid-acting insulin that works quickly to help control blood sugar during meals, while Humulin R is a short-acting insulin that also works relatively quickly but for a shorter duration. These differences in pharmacokinetics define how each type of insulin is utilized in diabetes management.